Raymond James & Associates’s Amyris Inc. AMRS Stock Holding History

Raymond James & Associates’s Portfolio AMRS Stock Details AMRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,000	Closed	-$8K	–	4097
2023 Q4	$8K	Hold	1,000	–	–	﹤0.01%	3809
2023 Q3	$8K	Hold	1,000	–	–	﹤0.01%	3771
2023 Q2	$8K	Sell	1,000 -16,600	-94%	-$15.5K	﹤0.01%	3816
2023 Q1	$91K	Sell	17,600 -20,800	-54%	-$29.7K	﹤0.01%	3667
2022 Q4	$1.92K	Sell	38,400 -15,600	-29%	-$34.8K	﹤0.01%	3899
2022 Q3	$22K	Sell	54,000 -9,800	-15%	-$26.7K	﹤0.01%	3790
2022 Q2	$16K	Buy	63,800 +46,200	+263%	+$136K	﹤0.01%	3896
2022 Q1	$23K	Hold	17,600	–	–	﹤0.01%	3989
2021 Q4	$39K	Sell	17,600 -30,400	-63%	-$284K	﹤0.01%	3978
2021 Q3	$221K	Buy	+48,000	New	+$687K	﹤0.01%	3612

Other funds holding AMRS

FCA Corp Houston, Texas $354M AUM 17.74% 1-Year Est. Return

CAM

Cozad Asset Management Champaign, Illinois $1.27B AUM 31.6% 1-Year Est. Return

TSMHT

Thurston Springer Miller Herd & Titak Indianapolis, Indiana $275M AUM 30.64% 1-Year Est. Return

Raymond James & Associates's AMRS Position: Q1 2024 in Review

Raymond James & Associates sold out of Amyris Inc. (AMRS) in Q1 2024, closing a stake of 14,219 shares — an estimated $36 sold.

Raymond James & Associates first reported a position in AMRS in Q3 2021 and held it in 10 quarters. The position peaked at $375K in Q3 2021. 3 funds tracked by Wall St. Rank hold AMRS as of Q1 2024.

Raymond James & Associates reported no remaining Amyris Inc. position as of Q1 2024 after selling out during the quarter.
Raymond James & Associates sold 14,219 Amyris Inc. shares in Q1 2024, an estimated $36.
Raymond James & Associates first reported a position in Amyris Inc. in Q3 2021 and held it in 10 quarters.
Raymond James & Associates's Amyris Inc. position peaked at $375K in Q3 2021.
3 funds tracked by Wall St. Rank held Amyris Inc. as of Q1 2024.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.